CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial

BACKGROUND: Adjuvant therapy improves the prognosis of stage II & III colon cancer patients. Unfortunately, most patients do not benefit from this treatment. PePITA (NCT00994864) is a prospective, multicenter, non-randomized study whose primary objective is to predict the outcome of adjuvant the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Rothé, Françoise, Maetens, Marion, Rouas, Ghizlane, Paesmans, Marianne, Van den Eynde, Marc, Van Laethem, Jean-Luc, Vergauwe, Philippe, Deboever, Guido, Bareche, Yacine, Vandeputte, Caroline, Ignatiadis, Michail, Hendlisz, Alain
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6446374/
https://ncbi.nlm.nih.gov/pubmed/30943928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5528-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados